61.36

0.23% 0.14

Pre-market: 60.81 -0.55 -0.90%

Dolby Laboratories Inc (DLB)

Overview News Price History Option Chain Financials Why DLB Down? Discussions Forecast Dividend History

Dolby Laboratories Inc stock is traded at $61.36, with a volume of 838.97K. It is up +0.23% in the last 24 hours and up +19.96% over the past month. Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.

Previous Close:

$61.22

Open:

$61.28

24h Volume:

838.97K

Relative Volume:

0.96

Market Cap:

$5.80B

Revenue:

$1.36B

Net Income/Loss:

$245.33M

P/E Ratio:

24.24

EPS:

2.531

Net Cash Flow:

$258.10M

1W Performance:

+16.79%

1M Performance:

+19.96%

6M Performance:

-4.08%

1Y Performance:

-15.47%

1-Day Range:

$60.32

$61.50

1-Week Range:

$51.13

$61.50

52-Week Range:

$48.26

$75.66

Dolby Laboratories Inc Stock (DLB) Company Profile

Name

Dolby Laboratories Inc

Sector

Industrials (702)

Industry

Specialty Business Services (42)

Phone

415 558 0200

Address

1275 MARKET STREET, SAN FRANCISCO, CA

Employee

2,051

Twitter

@dolby

Next Earnings Date

2026-07-30

Latest SEC Filings

DLB's Discussions on Twitter

Compare DLB vs CTAS, RELX, TRI, CPRT, RBA

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DLB Dolby Laboratories Inc	61.36	4.85B	1.36B	245.33M	258.10M	2.531
CTAS Cintas Corp	201.40	84.42B	11.26B	2.00B	1.88B	4.9083
RELX Relx Plc Adr	36.61	62.27B	12.64B	2.74B	3.15B	1.4777
TRI Thomson Reuters Corp	98.61	42.68B	7.66B	1.54B	2.08B	3.4015
CPRT Copart Inc	28.91	27.58B	4.64B	1.55B	1.34B	1.6051
RBA Rb Global Inc	95.63	21.68B	4.72B	449.90M	673.97M	2.158

Dolby Laboratories Inc Stock (DLB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-05-25	Initiated	Robert W. Baird	Neutral
May-15-25	Resumed	Tigress Financial	Buy
Jun-03-24	Upgrade	Barrington Research	Mkt Perform → Outperform
Nov-18-22	Downgrade	Barrington Research	Outperform → Mkt Perform
May-24-22	Initiated	Rosenblatt	Buy
Aug-02-21	Upgrade	Barrington Research	Mkt Perform → Outperform
Aug-04-20	Reiterated	B. Riley FBR	Neutral
Jun-24-20	Downgrade	B. Riley FBR	Buy → Neutral
Mar-24-20	Upgrade	B. Riley FBR	Neutral → Buy
Mar-13-20	Upgrade	JP Morgan	Neutral → Overweight
Jan-10-20	Downgrade	B. Riley FBR	Buy → Neutral
Aug-02-19	Reiterated	B. Riley FBR	Neutral
Oct-25-18	Reiterated	B. Riley FBR	Neutral
Sep-05-18	Initiated	R. F. Lafferty	Buy
Jul-26-18	Reiterated	B. Riley FBR	Neutral
Jan-16-18	Downgrade	B. Riley FBR, Inc.	Buy → Neutral
Oct-04-16	Resumed	JP Morgan	Neutral
Jul-28-16	Reiterated	Dougherty & Company	Buy
Apr-28-16	Reiterated	Dougherty & Company	Buy
Apr-25-16	Reiterated	Dougherty & Company	Buy
Apr-08-16	Downgrade	JP Morgan	Overweight → Neutral
Mar-28-16	Reiterated	Dougherty & Company	Buy
Jan-28-16	Upgrade	Dougherty & Company	Neutral → Buy
Apr-22-15	Upgrade	JP Morgan	Neutral → Overweight
Jan-22-15	Reiterated	B. Riley & Co.	Neutral

View All

Dolby Laboratories Inc Stock (DLB) Latest News

Jul 28, 2026

Entropy Technologies LP Makes New Investment in Dolby Laboratories $DLB - MarketBeat

Jul 28, 2026

Dolby Laboratories (NYSE:DLB) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jul 28, 2026

DLB|Dolby Laboratories Inc|Price:51.260|Chg%:+1.400 - TradingKey

Jul 28, 2026

Jul 27, 2026